At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,462 enrolled
Drug / intervention
Pancreaticoduodenectomy with portal vein resectionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Benchmarking Outcomes in Pancreatoduodenectomy With Portal Vein Resection - WhippleBenchmarks.Org
In Brief
An observational study evaluating Pancreaticoduodenectomy with portal vein resection for Pancreatic Neoplasms and Pancreaticoduodenectomy. Completed, enrolled 1,462 participants across 2 sites in 2 countries.
Detailed Summary
The WhippleBenchmark 2 Collaborative study aims at defining benchmark criteria for best achievable outcomes after pancreaticoduodenectomy with portal vein resection.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Neoplasms, Pancreaticoduodenectomy
CountriesSpain, United Kingdom
CollaboratorsSeoul National University Bundang Hospital, Cancer Institute Hospital, Japan, Hospital Curry Cabral, CHLC, Lisbon, Portugal, St. Joseph's Hospital of Atlanta, Erasmus Medical Center, Hospital Italiano de Buenos Aires, Juntendo University, Parc de Salut Mar, Queen Elizabeth Hospital NHS Foundation Trust, Rennes University Hospital, San Raffaele University Hospital, Italy, St Vincent's University Hospital, Ireland, Thomas Jefferson University, University of Dublin, Trinity College, University of Lyon, Mainz University, University of Pisa, Azienda Ospedaliera Universitaria Integrata Verona, University Hospital Southampton NHS Foundation Trust, University Hospital, Zürich, Amsterdam UMC, location VUmc, University of Colorado, Denver, Severance Hospital
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartAug 2019
First PostedAug 2019
Primary CompletionFeb 2020
Study CompletionFeb 2020
TodayJul 2026
First PostedAug 13, 2019
Enrollment StartAug 9, 2019
Primary CompletionFeb 10, 2020
Study CompletionFeb 20, 2020
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.9 years ago
Interventions
Pancreaticoduodenectomy with portal vein resectionprocedure
Pancreatic surgery with vein resection to achieve disease clearance.